Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
2022 Standout
Works of Joanne McCormack being referenced
Time to Treatment Response in First-Episode Schizophrenia
2011
Randomized Comparison of Olanzapine Versus Risperidone for the Treatment of First-Episode Schizophrenia: 4-Month Outcomes
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Joanne McCormack | 403 | 128 | 213 | 214 | 13 | 681 | |
| Arantzazu Zabala | 539 | 66 | 232 | 119 | 26 | 769 | |
| Qing Rui | 523 | 65 | 205 | 159 | 24 | 770 | |
| Thomas Walch | 401 | 83 | 138 | 79 | 15 | 770 | |
| F. Gomez-Mont | 363 | 67 | 350 | 258 | 11 | 780 | |
| Thérèse A. van Amelsvoort | 244 | 87 | 220 | 87 | 18 | 615 | |
| Mona McCalley-Whitters | 499 | 37 | 312 | 178 | 24 | 735 | |
| Yvonne Czechowska | 274 | 60 | 432 | 170 | 9 | 691 | |
| Ivan N. Waldman | 363 | 33 | 151 | 89 | 19 | 602 | |
| Elisabeth H. Lange | 408 | 60 | 392 | 192 | 17 | 698 | |
| Alexandra Roldán | 335 | 62 | 201 | 77 | 23 | 618 |
All Works
Loading papers...